{"title":"桧木醇通过诱导细胞凋亡和抑制细胞迁移,在人口腔鳞状细胞癌中显示出强大的抗癌作用","authors":"Hideki Yoshimatsu , Ryuhei Kanda , Lyu Xinghui , Keita Kano","doi":"10.1016/j.ajoms.2025.02.019","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Hinokitiol (HNK) has been shown to have various pharmacological effects, including anti-inflammatory and anti-bacterial activities, against various diseases. However, its effects on oral cancer have not been reported. Therefore, we investigated the anti-cancer activity and mechanism of action of HNK in oral squamous cell carcinoma (OSCC).</div></div><div><h3>Methods</h3><div>Cell viability was measured using the MTT assay, while apoptosis was assessed through DAPI staining, TUNEL assay, annexin V/propidium iodide (PI) staining, and flow cytometry. Cell migration capacity was evaluated using a wound-healing assay.</div></div><div><h3>Results</h3><div>Our findings indicate that HNK inhibits the proliferation of HSC-2 cells in a dose-dependent manner. Additionally, our evaluation revealed that HNK exerts its anticancer effects by inducing apoptosis. Moreover, HNK inhibited the migration of HSC-2 cells in a dose-dependent manner.</div></div><div><h3>Conclusions</h3><div>Based on our results, we conclude that HNK has the potential as an important lead compound in treating OSCC. Moreover, HNK inhibits OSCC by inducing apoptosis and suppressing cell migration.</div></div>","PeriodicalId":45034,"journal":{"name":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","volume":"37 5","pages":"Pages 1038-1043"},"PeriodicalIF":0.4000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hinokitiol exhibits potent anticancer effects in human oral squamous cell carcinoma by inducing apoptosis and inhibition of cell migration\",\"authors\":\"Hideki Yoshimatsu , Ryuhei Kanda , Lyu Xinghui , Keita Kano\",\"doi\":\"10.1016/j.ajoms.2025.02.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Hinokitiol (HNK) has been shown to have various pharmacological effects, including anti-inflammatory and anti-bacterial activities, against various diseases. However, its effects on oral cancer have not been reported. Therefore, we investigated the anti-cancer activity and mechanism of action of HNK in oral squamous cell carcinoma (OSCC).</div></div><div><h3>Methods</h3><div>Cell viability was measured using the MTT assay, while apoptosis was assessed through DAPI staining, TUNEL assay, annexin V/propidium iodide (PI) staining, and flow cytometry. Cell migration capacity was evaluated using a wound-healing assay.</div></div><div><h3>Results</h3><div>Our findings indicate that HNK inhibits the proliferation of HSC-2 cells in a dose-dependent manner. Additionally, our evaluation revealed that HNK exerts its anticancer effects by inducing apoptosis. Moreover, HNK inhibited the migration of HSC-2 cells in a dose-dependent manner.</div></div><div><h3>Conclusions</h3><div>Based on our results, we conclude that HNK has the potential as an important lead compound in treating OSCC. Moreover, HNK inhibits OSCC by inducing apoptosis and suppressing cell migration.</div></div>\",\"PeriodicalId\":45034,\"journal\":{\"name\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"volume\":\"37 5\",\"pages\":\"Pages 1038-1043\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2025-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oral and Maxillofacial Surgery Medicine and Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212555825000596\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral and Maxillofacial Surgery Medicine and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212555825000596","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Hinokitiol exhibits potent anticancer effects in human oral squamous cell carcinoma by inducing apoptosis and inhibition of cell migration
Objective
Hinokitiol (HNK) has been shown to have various pharmacological effects, including anti-inflammatory and anti-bacterial activities, against various diseases. However, its effects on oral cancer have not been reported. Therefore, we investigated the anti-cancer activity and mechanism of action of HNK in oral squamous cell carcinoma (OSCC).
Methods
Cell viability was measured using the MTT assay, while apoptosis was assessed through DAPI staining, TUNEL assay, annexin V/propidium iodide (PI) staining, and flow cytometry. Cell migration capacity was evaluated using a wound-healing assay.
Results
Our findings indicate that HNK inhibits the proliferation of HSC-2 cells in a dose-dependent manner. Additionally, our evaluation revealed that HNK exerts its anticancer effects by inducing apoptosis. Moreover, HNK inhibited the migration of HSC-2 cells in a dose-dependent manner.
Conclusions
Based on our results, we conclude that HNK has the potential as an important lead compound in treating OSCC. Moreover, HNK inhibits OSCC by inducing apoptosis and suppressing cell migration.